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Abstract: Phellinus linteus is a well-known medicinal mushroom that is widely used in Asian countries.
In several experimental models, Phellinus linteus extracts were reported to have various biological
effects, including anti-inflammatory, anti-cancer, hepatoprotective, anti-diabetic, neuroprotective,
and anti-angiogenic activity. In the present study, several bioactive compounds, including palmitic
acid ethyl ester and linoleic acid, were identified in Phellinus linteus. The intermediate-conductance
calcium-activated potassium channel (IKCa) plays an important role in the regulation of the vascular
smooth muscle cells’ (VSMCs) contraction and relaxation. The activation of the IKCa channel causes
the hyperpolarization and relaxation of VSMCs. To examine whether Phellinus linteus extract causes
vasodilation in the mesenteric arteries of rats, we measured the isometric tension using a wire
myograph. After the arteries were pre-contracted with U46619 (a thromboxane analogue, 1 µM),
Phellinus linteus extract was administered. The Phellinus linteus extract induced vasodilation in
a dose-dependent manner, which was independent of the endothelium. To further investigate
the mechanism, we used the non-selective K+ channel blocker tetraethylammonium (TEA). TEA
significantly abolished Phellinus linteus extract-induced vasodilation. Thus, we tested three different
types of K+ channel blockers: iberiotoxin (BKca channel blocker), apamin (SKca channel blocker),
and charybdotoxin (IKca channel blocker). Charybdotoxin significantly inhibited Phellinus linteus
extract-induced relaxation, while there was no effect from apamin and iberiotoxin. Membrane
potential was measured using the voltage-sensitive dye bis-(1,3-dibutylbarbituric acid)-trimethine
oxonol (DiBAC4(3)) in the primary isolated vascular smooth muscle cells (VSMCs). We found that
the Phellinus linteus extract induced hyperpolarization of VSMCs, which is associated with a reduced
phosphorylation level of 20 KDa myosin light chain (MLC20).
Keywords: Phellinus linteus; Kca channels; vasodilation; relaxation; mesenteric artery
1. Introduction
Resistance arteries are blood vessels that have a small diameter in the microcirculation that
contributes to regulation of blood pressure and the distribution of cardiac output within the tissues
and organs to meet their physiological demands [1]. The arterial wall consists of a single layer of
endothelial cells, vascular smooth muscle cells, elastic fibers, and other extracellular matrix elements.
Vascular smooth muscle cells (VSMCs) play significant roles in the functioning of arteries [2]. VSMCs
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cause the contraction and relaxation of the vascular wall and hence contribute to the regulation of
blood flow.
Smooth muscle cells of resistance arteries express various ion channels, including calcium-activated
potassium channels (Kca channels) [3]. The Kca channels are a group of abundant K+ channels
that are activated by increase in intracellular Ca2+ concentration, including the small-conductance
calcium-activated potassium channel (SKca), the intermediate-conductance calcium-activated potassium
channel (IKca), and large-conductance calcium-activated potassium (BKca) channels. The activation of
Kca channels enables K+ efflux, resulting in hyperpolarization and causing vasodilation. Thus, Kca
channel activity is one of the major determinants for vascular tone [4].
Phellinus linteus is a well-known medicinal mushroom that is widely used in Korea, Japan,
China, and other Asian countries [5]. In several experimental models, it has been reported that
Phellinus linteus extract contains various phenolic compounds that exert various biological effects,
including anti-inflammatory [6,7], anti-cancer [8,9], hepatoprotective [10,11], anti-diabetic [12,13],
and neuroprotective [14,15] effects. Recently, it has been shown that Phellinus linteus exhibited
anti-angiogenic activity in mice [16,17]. Although the biological activities of Phellinus linteus extract
have been widely reported, the vascular effect of Phellinus linteus extract has not been investigated.
Thus, in the present study, we investigated whether Phellinus linteus extract has effects on the mesenteric
resistance arteries of rats, and if so, what the underlying mechanisms were.
2. Results
2.1. Gas Chromatograms of the Compounds in Phellinus linteus Extract
The gas chromatogram of the compounds identified in the sample of Phellinus linteus extract
is demonstrated in Figure 1. The identities of eight compounds were determined, along with their
retention time (Table 1). The compounds identified based on the gas chromatography–mass spectrometry
(GC/MS) analysis include palmitic acid ethyl ester, linoleic acid, linoleic acid ethyl ester, lichesterol,
5,6-dihydroergosterol, 7-ergostenol, lupenone, and betulin (Table 1).
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Table 1. Bioactive compounds detected in Phellinus linteus extract. (PK: peak, RT: retention time).
PK RT (min) Tentative Compounds Total (%)
1 19.68 palmitic acid ethyl ester 3.48
2 21.03 linoleic acid 10.39
3 21.27 linoleic acid ethyl ester 15.86
4 28.93 lichesterol 2.59
5 29.25 5,6-dihydroergosterol 3.26
6 29.69 7-ergostenol 2.80
7 30.40 lupenone 3.24
8 34.03 betulin 2.19
2.2. Effect of Phellinus linteus Extract on Agonist-Induced Contraction in Mesenteric Arteries of Rats
Phellinus linteus extract induced relaxation in a dose-dependent manner in the rats’ mesenteric
arteries pre-contracted with U46619 (1 µM) and phenylephrine (5 µM) (Figure 2(A1,A2)). There was no
difference in vasodilatory effect of Phellinus linteus extract between U46619- and phenylephrine-induced
contraction (Figure 2(A3)). The vehicle, dimethyl dulfoxide (DMSO, maximum of 0.4%) had no
significant effect on the U46619-induced contraction (Figure 2 inset). To compare the effect of
Phellinus linteus extract with another vasodilator, aceylcholine was administered in a U46619-induced
contraction (Figure 3). Acetylcholine induced dose-dependent relaxation in a U46619-induced
contraction in endothelium-intact mesenteric arteries (Figure 3(B1)), which was significantly abolished
by endothelium removal (Figure 3(B2,B3)). These results suggested that Phellinus linteus extract can act
as a vasodilator in the mesenteric arteries of rats.
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Phellinus linteus extract in e dothelium intact mesenteric rter re-contracted with U46619 (1 µM).
(B) Relax tion by Phellinus linteus extract i e t li enuded mesenteric artery pre-contracted
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of l– NA (3 0 µM). (D) Statistical analy is of the relaxation response of Phellinus linteus extract.
Relax tion of arteries is expres ed as t t e of the contraction induced by U46619 (1 µM).
Mean ± SD. (n = 5). (l– itro–l–arginine).
2.3. Phellinus linteus Extract-Induced Endothelium-Independent Relaxation
To investigate the underlying mechanisms of Phellinus linteus extract-induced relaxation,
Phellinus linteus extract was applied in endotheliu -intact and endothelium-d nuded mesenteric
arteries (Figure 3A,B). There was no significant difference between endothelium-intact and
endothelium-denuded mesenteric rteries. To confirm th effect of Phe linus linteus extract on the
end th lium, the mese teric arteries were pre-incubated with the endothelial nitric xide synt ase
(eNOS) inhibitor nomega–nitro–l–arginine (l–NNA, 300 µM) for 20 min before being contracted with
U46619 (1 µM, Figure 3C). The l–NNA did not affect the Phellinus linteus extract-induced relaxation,
indicating that the relaxation effect of Phellinus linteus extract was not related to the endothelium.
This result suggests that Phellinus linteus extract-induced relaxation is endothelium-independent.
2.4. Inhibition of Phellinus linteus Extract-Induced Relaxation by K+ Channel Blockers
To clarify the underlying mechanisms of the Phellinus linteus extract-induced relaxation,
the mesenteric arteries were incubated with tetraethylammonium (TEA, 2 mM, Figure 4A), apamin
(50 nM, Figure 4B), iberiotoxin (100 nM, Figure 4C), or charybdotoxin (20 nM, Figure 4D) for 20 min,
and then Phellinus linteus extract was added. The non-selective K+ channel blocker, TEA, and the IKca
blocker, charybdotoxin, significantly inhibited Phellinus linteus extract-induced relaxation, while the
SKca channel blocker, the apamin, and the BKca channel blocker iberiotoxin did not affect the
Phellinus linteus extract-induced vasodilation (Figure 4E). These results indicate that the IKca channel is
involved in the relaxation induced by Phellinus linteus extract.
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2.5. Effect of Phellinus linteus Extract on the Membrane Potential and Phosphorylation of 20 KDa Myosin Light
Chain (MLC20)
To clarify whether Phellinus linteus extract-induced relaxation was produced by hyperpolarization
in VSMCs, we measured the membrane potential using the vol age sen itive dye bis-(1,3-dibarbituric
acid)-trimethine oxanol (DiBAC4(3)) and btained confocal im ges. The appli ati n of U46619 (1 µM)
increased the fluorescence intensity of the membrane pot tial in VSMCs compar d to th control group.
In the presence of Phellinus linteus extract (200 ng/mL), U46619 did not increase the fluorescence intensity
of the membrane potential in the VSMCs (Figure 5A). To investigate whether the Phellinus linteus
extract-induced relaxation was caused by the decreased phosphorylation of MLC20, we measured
the phosphorylation and the expression level of MLC20 in the VSMCs (Figure 5). The administration
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of U46619 increased the phosphorylation level of MLC20 in the VSMCs compared to the control
group. In the presence of Phellinus linteus extract, U46619 did not increase the phosphorylation level of
MLC20 (Figure 5B). These results suggested that Phellinus linteus extract induced hyperpolarization
and inhibited the subsequent phosphorylation of MLC20 in U46619-treated VSMCs.
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20 KDa myosin light chain (MLC20). (A) Representative images of fluorescence intensity of DiBAC4(3)
in control VSMCs, VSMCs treated with U46619 (1 µM), and VSMCs co-treated with U46619 (1 µM) and
Phellinus linteus extract (200 ng/mL) (scale bar: 50 µm). (B) Representative western blot analysis and
quantitative data for phosphorylated MLC20 (P–MLC20) and total MLC20 (T–MLC20) in control VSMCs,
VSMCs treated with U46619 (1 µM), and VSMCs co-treated with U46619 (1 µM) and Phellinus linteus
extract (200 ng/mL). * p < 0.05 for VSMCs treated with U46619 vs. VSMCs co-treated with U46619 and
Phellinus linteus extract. (n = 4).
3. Discussion
In this study, we investigated the vasodilatory effect of Phellinus linteus extract on the mesenteric
arteries of rats. We found that this effect was independent of the endothelium. The mechanism of
vasodilation induced by the Phellinus linteus extract involved the IKCa channel. The non-selective K+
channel blocker TEA and the specific IKCa channel blocker charybdotoxin inhibited the relaxation
induced by the Phellinus linteus extract. We also found that the Phellinus linteus extract induced
hyperpolarization of the VSMCs, which caused a decrease of the phosphorylated MLC20 and subsequent
vasodilation of the mesenteric arteries.
In several experimental models, it has been reported that Phellinus linteus extract has several strong
biological activities, such as anti-oxidative, immune-modulating, hypoglycemic, and hepatoprotective
effect [18–21]. However, the vascular effect of Phellinus linteus extract has not been assessed. Thus,
the present study is the first investigation to explore the vascular effect of this extract in resistance arteries.
The vasodilatory effect of Phellinus linteus extract remained in endothelium-denuded mesenteric arteries
of rats and in endothelium-intact arteries in the presence of l–NNA. Thus, the relaxation caused by
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the extract was independent of the endothelium. We found in the Phellinus linteus extract various
compounds, including palmitic acid ethyl ester, linoleic acid, linoleic acid ethyl ester, lichesterol,
5,6-dihydroergosterol, 7-ergostenol, lupenone, and betulin. We assume that linoleic acid could play a
critical role in the relaxation induced by Phellinus linteus extract since it has been reported that linoleic
acid induced relaxation and hyperpolarization in the coronary arteries of pigs [22]. However, further
studies are needed to clarify the exact compound that causes relaxation.
Vascular smooth muscle contraction is initiated by an elevation of intracellular Ca2+, which can
result from either extracellular Ca2+ influx through calcium channels, or Ca2+ release from sarcoplasmic
reticulum (SR). Extracellular Ca2+ influx via the voltage gated Ca2+ channel can be evoked by membrane
depolarization. Inhibition of the K+ channels contributes to membrane depolarization. By contrast,
activation of the K+ channels enables K+ efflux and leads to membrane hyperpolarization, which
contributes to the closure of the voltage-dependent Ca2+ channels to block the influx of extracellular
Ca2+, thereby inducing relaxation of the smooth muscle cells [23].
It is well known that at least four different types of K+ channels are expressed in VSMCs, including
KCa channels, voltage-gated K+ (Kv) channels, ATP-sensitive K+ (KATP) channels, and inward-rectifier
K+ channels [24]. KCa channels play a functional role by coupling the increase of intracellular Ca2+ to
the hyperpolarization of the membrane potential. This feature enables KCa channels to play key roles in
regulating cell excitability and K+ homeostasis [25]. The KCa channels are divided into three subfamilies
that include small conductance KCa (SKCa) channels, large or big KCa (BKCa), and intermediate KCa
(IKCa). It has been reported that the IKCa channel seems to be involved in the VSMCs proliferation [26]
and vasodilation of porcine coronary arteries [27].
In the present study, we found that Phellinus linteus extract-induced relaxation was abolished
in the presence of the non-selective K+ channel inhibitor TEA. Thus, we assumed that the K+
channel is involved in the extract-induced vasodilation. To delineate which K+ channel is involved
in the Phellinus linteus extract-induced relaxation, we used specific blockers of BKca (iberiotoxin),
SKca (apamin), and IKca (charybdotoxin) channels. Interestingly, charybdotoxin significantly
inhibited Phellinus linteus extract-induced relaxation, while apamin and iberiotoxin did not affect the
extract-induced vasodilation. Charybdotoxin is known to block several KCa channels [28], however it
is also known to specifically block the IKca channel in a concentration between 20 and 300 nM [29–31].
Additionally, in the present study we used a low dose (20 nM) of charybdotoxin to block only the IKca
channel. Thus, we assume that the IKca channel could be involved in Phellinus linteus extract-induced
vasodilation. To confirm the effect of the Phellinus linteus extract, we measured the membrane potential
with the voltage-sensitive dye DiBAC4(3) in the primary isolated VSMCs. The membrane potential
is one of the major contributors to the contractile activity of VSMCs. The activation of the IKCa
channel and subsequent K+ efflux leads to membrane hyperpolarization, which causes vasodilation.
We found that Phellinus linteus extract induced hyperpolarization of VSMCs. This result is consistent
with the previous report that showed that Phellinus linteus extract induced hyperpolarization in a
concentration-dependent manner in monocytes [15].
The increase of intracellular Ca2+ concentration activates Ca2+/calmodulin-dependent myosin
light chain kinase (MLCK) and the phosphorylation of 20 KDa myosin light chain (MLC20) and thus
induces smooth muscle contraction. The decrease of intracellular Ca2+ induces dephosphorylation of
the MLC20 and thus smooth muscle relaxation [32,33]. Therefore, the phosphorylation of MLC20 is
considered to be a key regulation step in smooth muscle contraction and relaxation. In the present
study, we found that phosphorylated MLC20 is decreased in Phellinus linteus extract-treated VSMCs.
These results indicate that the relaxation induced by Phellinus linteus extract involves hyperpolarization
via IKca channel activation and subsequent decrease in MLC20 phosphorylation.
In conclusion, Phellinus linteus extract induces endothelium-independent relaxation in the
mesenteric arteries of rats, and this effect involves the opening of IKCa channels, thereby hyperpolarizing
the VSMCs. Thus, the IKCa channel may be a cellular target for the vasodilatory effects of Phellinus linteus
extract in the vasculature.
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4. Methods
All experiments were performed according to the Guide for the Care and Use of Laboratory
Animals, published by the US National Institutes of Health (NIH publication No. 85-23, 2011) and
were approved by the Ethics Committee and the Institutional Animal Care and Use Committee of
Yonsei University College of Medicine (Approval number: 2019-0278).
4.1. Phellinus linteus Extract Preparation
Dried Phellinus linteus was purchased from the Gyeong-dong medicinal herb market (Seoul,
Korea). The sample (1 kg) was ground into a powder and mixed in ethanol (5 L) by shaking for 24 h at
125 rpm (1.57× g). The ethanol extract was filtered through No. 42 filter paper (Whatman International
Ltd., Middlesex, UK) with five replicates, and evaporated in a rotary evaporator (Eyela, Tokyo, Japan)
under reduced pressure at 37 ◦C.
4.2. Gas Chromatography–Mass Spectrometry (GC/MS) Analysis
GC/MS analysis was performed by an Agilent 7890B gas chromatograph, equipped with a 5977A
mass selective detector quadrupole mass spectrometer system (Palo Alto, CA, USA). The DB-5 MS
capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness, 5% diphenyl-95% dimethylsiloxane
phase) was obtained from J&W Scientific (Folsom, CA, USA). The GC oven temperature was maintained
at 60 ◦C for 3 min, and then ramped to 320 ◦C at 10 ◦C per min. The sample was injected in the split
mode, at a splitting ratio of 1:30. The temperatures of the GC injection port and MS interface were
set at 300 ◦C. The mass selective detector was run in the electron impact (EI) mode, with an electron
energy at 70 eV. The mass spectrometer was operated in the full scan mode between 40 and 600 amu.
For the identification of the compounds, EI mass spectral library search (Wiley registry 7n edition,
Wiley Science Solutions, Hoboken, NJ, USA) was used.
4.3. Tissue Preparation
In this experiment, 12-week-old male Sprague Dawley rats were used. The rats were sacrificed
with isoflurane (5%), followed by CO2 inhalation. To confirm death, the rats were carefully checked
for several signs, such as no response to toe pinch, no palpable heartbeat, and color change opacity
in the eyes. After we confirmed death, the heart was excised immediately and then the mesenteric
artery beds were removed and placed in ice-cold Krebs–Henseleit (K–H) solution (composition in mM:
NaCl, 119; CaCl2, 2.5; NaHCO3, 25; MgSO4, 1.2; KH2PO4, 1.2; KCl, 4.6; and glucose, 11.1). Connective
tissues and adipose tissues were removed under an optical microscope (model SZ-40, Olympus, Tokyo,
Japan). The second or third branches of the mesenteric arteries (200–250 µm, inner diameter) were
isolated and cut into 2–3 mm segments for subsequent analysis.
4.4. Isometric Tension Recording
The mesenteric artery segments were mounted in a myograph chamber (DMT, Arhaus, Denmark)
for recording of isometric tension. Briefly, two steel wires (40 µm in diameter) were inserted into the
lumen of the artery and then mounted according to the methods previously described [34]. After a
30-min equilibration period in a K–H solution bubbled with 5% CO2 + 95% O2 at 37 ◦C, the arteries
were stretched to their optimal lumen diameter for active tension development. Vessel contractility was
tested by exposure to a high K+ (70 mM) solution. Where required, the endothelium was mechanically
denuded by rubbing the inner surface of an arterial segment with a wire. Removal of the endothelium
was confirmed by the absence of relaxation from acetylcholine (10 µM) in the U46619 (thromboxane
analogue, 1 µM) pre-contracted artery. After another wash step, the rings of the mesenteric arteries were
pre-contracted with U46619 (1 µM), and at the steady maximal contraction, cumulative dose-response
curves were obtained for the Phellinus linteus extract. To determine the involvement of the endothelium,
the arteries were pre-incubated with l–NNA (300 µM), a nitric oxide synthase inhibitor, for 20 min
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before being contracted with U46619 (1 µM). To determine the effects of the Kca channel blockers
on vasodilation, the arterial segments were pre-treated with TEA (2 mM), iberiotoxin (100 nM),
charybdotoxin (20 nM), or apamin (50 nM) for 20 min, then U46619 was administered.
4.5. Isolation and Culture of Vascular Smooth Muscle cells (VSMCs)
Vascular smooth muscle cells (VSMCs) were obtained as previously described [35]. Briefly,
the aortas were excised, and fat and connective tissues were removed. And the lumen of the aorta was
gently rubbed for removal of the endothelium. The aortas were cut into small segments and transferred
into a tube containing elastase (0.5 mg/mL, Calbiochem, San Diego, CA, USA) and collagenase (1 mg/mL,
Worthington Biomedical Corporation, Lakewood Township, NJ, USA) in Dulbecco’s Modified Eagle
Medium (DMEM, Gibco, Waltham, MS, USA) at 37 ◦C for 30 min. After trituration and centrifugation,
the cells were seeded in culture dishes (Corning, New York, NY, USA) and cultivated in DMEM
supplemented with 10% fetal bovine serum (FBS, Gibco), 100 IU/mL penicillin (Gibco), and 100 µg/mL
streptomycin (Gibco) at 37 ◦C, 5% CO2 with a humidified atmosphere. The early passage cells (between
2 and 4) were used.
4.6. Western Blot Analysis
The cultured VSMCs were frozen in liquid nitrogen after treatment with U46619, with or
without Phellinus linteus extract. VSMCs were homogenized in an ice-cold lysis buffer, as described
previously [36]. Western blot analysis was performed for total MLC20 and phosphorylated MLC20
(1:1000 dilution; Cell signaling, Boston, MA, USA). The blots were stripped and then reprobed with the
β-actin antibody (1:2000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) to verify equal
loading between the samples.
4.7. Determination of Membrane Potential of Vascular Smooth Muscle Cells by Confocal Microscopy
The cells were seeded in a plate coated with poly–l–lysine for 24 h, then incubated with membrane
potential-sensitive fluorescent dye DiBAC4(3) (5 µM) for 20 min. U46619 (1 µM) and Phellinus linteus
extract (200 ng/mL) were added to the cells for 10 min, and the cells were washed with PBS 2–3 times.
The cells were then fixed with formaldehyde (4%).
4.8. Drugs
The following drugs were used: U46619 (Tocris Bioscience, Ellisville, MO, USA), acetylcholine
(Sigma-Aldrich, St Louis, MO, USA), DiBAC4(3) (Biotium, Fremont, CA, USA), and general laboratory
reagents (Sigma-Aldrich, St Louis, MO, USA).
4.9. Statistical Analysis
Results were expressed as mean ± SD. One-way or two-way ANOVA was used to compare each
parameter when appropriate. Comparisons between groups were performed with t-tests when the
ANOVA test was statistically significant. Values of p < 0.05 were considered significant. Differences
between specified groups were analyzed using the Student t test (2-tailed) for comparing two groups,
with p < 0.05 considered statistically significant.
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